scholarly journals PITYRIASIS RUBRA PILARIS TYPE I ASSOCIATED WITH CIRRHOSIS OF THE LIVER

2021 ◽  
Vol 22 (2) ◽  
pp. 173-181
Author(s):  
Alina Maria VÎLCEA ◽  
Loredana Elena STOICA ◽  
Tiberiu Ștefăniță ȚENEA COJAN ◽  
Cecil Sorin MIREA ◽  
Simona BĂNICIOIU COVEI
Author(s):  
G. Licata ◽  
A. Gambardella ◽  
G. Calabrese ◽  
F. Pagliuca ◽  
R. Alfano ◽  
...  

2010 ◽  
Vol 14 (4) ◽  
pp. 185-188 ◽  
Author(s):  
Yao-Hua Zhang ◽  
Youwen Zhou ◽  
Nigel Ball ◽  
Ming-Wan Su ◽  
Jin-Hua Xu ◽  
...  

Background: Pityriasis rubra pilaris (PRP) has unknown etiology and is often refractory to conventional therapies. Objective: To document a PRP patient's response to adalimumab therapy and to highlight the potential role of tumor necrosis factor (TNF) in the development of PRP skin lesions. Methods: A patient received adalimumab therapy at standard dosing intervals. In addition, the messenger ribonucleic acid (mRNA) of TNF in the lesional and perilesional normal skin was quantified in two patients with PRP. Results: The patient responded to adalimumab therapy and achieved clinical remission by 4 months. There was a significant elevation of TNF mRNA in the lesional skin of PRP. Conclusion: TNF upregulation is detected in PRP lesional skin, consistent with the observed clinical efficacy of TNF blockade for the treatment of PRP.


2006 ◽  
Vol 47 (2) ◽  
pp. 124-129 ◽  
Author(s):  
Shobhan Manoharan ◽  
Stephen White ◽  
Krishna Gumparthy

2014 ◽  
Vol 105 (10) ◽  
pp. 955-957
Author(s):  
C. Martín Callizo ◽  
J. Molinero Caturla ◽  
J. Sánchez Sánchez ◽  
R.M. Penín Mosquera

2019 ◽  
Vol 5 (3) ◽  
pp. 194
Author(s):  
Kimberly Huerth ◽  
Wen Chen ◽  
Pooja Khera ◽  
Mary Maiberger

2019 ◽  
Vol 29 (5) ◽  
pp. 524-537
Author(s):  
Carina Engelmann ◽  
Peter Elsner ◽  
Diana Miguel

2007 ◽  
Vol 158 (3) ◽  
pp. 642-644 ◽  
Author(s):  
D. Seckin ◽  
E. Tula ◽  
T. Ergun

2018 ◽  
Vol 4 (8) ◽  
pp. 774-776 ◽  
Author(s):  
Mark D. Heibel ◽  
Haley D. Heibel

Sign in / Sign up

Export Citation Format

Share Document